New Zealand markets closed

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
87.28+1.16 (+1.35%)
At close: 04:00PM EDT
87.28 0.00 (0.00%)
After hours: 04:02PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.57B
Enterprise value 1.26B
Trailing P/E 16.31
Forward P/E 25.58
PEG ratio (5-yr expected) N/A
Price/sales (ttm)13.13
Price/book (mrq)1.94
Enterprise value/revenue 5.77
Enterprise value/EBITDA 30.36

Trading information

Stock price history

Beta (5Y monthly) 0.92
52-week change 312.49%
S&P500 52-week change 326.27%
52-week high 394.57
52-week low 349.24
50-day moving average 374.52
200-day moving average 367.33

Share statistics

Avg vol (3-month) 3189.09k
Avg vol (10-day) 3191.41k
Shares outstanding 517.96M
Implied shares outstanding 617.96M
Float 817.6M
% held by insiders 12.44%
% held by institutions 194.06%
Shares short (30 Apr 2024) 4795.62k
Short ratio (30 Apr 2024) 45.02
Short % of float (30 Apr 2024) 46.25%
Short % of shares outstanding (30 Apr 2024) 44.43%
Shares short (prior month 28 Mar 2024) 4672.08k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 402 Jul 2010
Last split factor 21603:1000
Last split date 302 Nov 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 81.43%
Operating margin (ttm)9.65%

Management effectiveness

Return on assets (ttm)-0.10%
Return on equity (ttm)13.26%

Income statement

Revenue (ttm)118.31M
Revenue per share (ttm)6.77
Quarterly revenue growth (yoy)-29.60%
Gross profit (ttm)N/A
EBITDA 33.89M
Net income avi to common (ttm)96.34M
Diluted EPS (ttm)5.35
Quarterly earnings growth (yoy)105.30%

Balance sheet

Total cash (mrq)310.59M
Total cash per share (mrq)17.29
Total debt (mrq)6.19M
Total debt/equity (mrq)0.77%
Current ratio (mrq)20.70
Book value per share (mrq)45.00

Cash flow statement

Operating cash flow (ttm)34.36M
Levered free cash flow (ttm)-5.32M